Drug Type Small molecule drug |
Synonyms Aladotril, Alatriopril, Fasidotrilat + [4] |
Target |
Mechanism ACE inhibitors(Angiotensin-converting enzyme inhibitors), enkephalinase inhibitors(Neprilysin inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H25NO6S |
InChIKeyKKBIUAUSZKGNOA-HNAYVOBHSA-N |
CAS Registry135038-57-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart Failure | Phase 3 | FR | - | |
Hypertension | Phase 3 | FR | - | |
Myocardial Infarction | Phase 3 | FR | - |